中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 协和医学杂志, 2022, 13(2): 203-226. DOI: 10.12290/xhyxzz.2022-0097
引用本文: 中华医学会感染病学分会艾滋病丙型肝炎学组,中国疾病预防控制中心. 中国艾滋病诊疗指南(2021年版)[J]. 协和医学杂志, 2022, 13(2): 203-226. DOI: 10.12290/xhyxzz.2022-0097
Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 203-226. DOI: 10.12290/xhyxzz.2022-0097
Citation: Acquired Immunodeficiency Syndrome and Hepatitis C Professional Group, Society of Infectious Diseases, Chinese Medical Association, Chinese Center for Disease Control and Prevention. Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)[J]. Medical Journal of Peking Union Medical College Hospital, 2022, 13(2): 203-226. DOI: 10.12290/xhyxzz.2022-0097

Chinese Guidelines for Diagnosis and Treatment of Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome(2021 edition)

  • 摘要: 2005年中华医学会感染病学分会艾滋病丙型肝炎学组制订了第一版《艾滋病诊疗指南》,并于2011年、2015年和2018年分别进行了更新。2021年版指南是在第四版指南的基础上进行修订,并根据我国临床实践和最新研究结果进行了内容更新。本版指南更新了机会性感染、抗反转录病毒治疗、暴露后预防、暴露前预防、人类免疫缺陷病毒感染全程管理和预防母婴传播方面的最新研究进展,详细介绍了暴露前预防的适应证、用药方案、随访/监测以及预防措施。本版指南将根据最新临床研究证据定期进行更新。

     

    Abstract: In 2005, the first edition of the guidelines for the diagnosis and treatment of acquired immunodeficiency syndrome(AIDS) was formulated by the AIDS Professional Group of the Society of Infectious Diseases of Chinese Medical Association, which was updated in 2011, 2015, and 2018, respectively. The 2021 edition of the guidelines was revised on the basis of the fourth edition and updated according to the national clinical practice and the latest research results. The new research progress in opportunistic infections, antiretroviral therapy, post-exposure prophylaxis (PEP), pre-exposure prophylaxis (PrEP), the whole course of the management of HIV infection, and prevention of mother to child transmission was updated in these guidelines. In the 2021 edition, the indications, medication regimen, follow-up and monitoring, and precautions of PrEP are introduced in detail. This edition of guidelines will be updated regularly according to the latest clinical evidence.

     

/

返回文章
返回